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Leena Peltonen, Antti Isomäki, and Clare J. Strachan*A wide variety of nanoparticles are playing an increasingly important role in
drug delivery. Label-free imaging techniques are especially desirable to follow
the cellular uptake and intracellular fate of nanoparticles. The combined
correlative use of different techniques, each with unique advantages,
facilitates more detailed investigation about such interactions. The synergistic
use of correlative coherent anti-Stokes Raman scattering and electron
microscopy (C-CARS-EM) imaging offers label-free, chemically-specific, and
(sub)-nanometer spatial resolution for studying nanoparticle uptake into cells
as demonstrated in the current study. Coherent anti-Stokes Raman scattering
(CARS) microscopy offers chemically-specific (sub)micron spatial resolution
imaging without fluorescent labels while transmission electron microscopy
(TEM) offers (sub)-nanometer scale spatial resolution and thus visualization
of precise nanoparticle localization at the sub-cellular level. This proof-of-
concept imaging platform with unlabeled drug nanocrystals and macrophage
cells revealed good colocalization between the CARS signal and electron
dense nanocrystals in TEM images. The correlative TEM images revealed
subcellular localization of nanocrystals inside membrane bound vesicles,
showing multivesicular body (MVB)-like morphology typical for late endo-
somes (LEs), endolysosomes, and phagolysosomes. C-CARS-EM imaging has
much potential to study the interactions between a wide range of nano-
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Much attention is being devoted to the use
of nanoparticles to overcome several
issues related to drug treatment and
facilitate the development of efficient
and safe medicines. They can be used,
for example, to improve the bioavailability
of poorly water-soluble drugs or for
targeted drug delivery, especially in cancer
treatment.[1] Suitable imaging techniques
are required to follow the precise fate
of these nanoparticles in biological matri-
ces, such as cells and tissues. This is
especially important when nanomedicines
are used to carry the active pharmaceutical
ingredient (API) into the cell, when the
biological target is located intracellularly.[2]
Cellular internalization of nanoparticles
can occur via different endocytosis mech-
anisms depending on the cell type and
physicochemical properties of the nano-
particles, e.g., particle shape and surface
charge.[2] The most common technique
used to image cells, tissues, and cellular
uptake of nanoparticles is fluorescence
microscopy.[3] Even though fluorescencecherließ
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www.advancedsciencenews.com www.biotechnology-journal.commicroscopy allows efficient visualization of nanoparticles and
diverse cell organelles, labeling is required in the absence of
autofluorescence. There are drawbacks to labeling nano-
particles. Such labels can affect drug function and delivery.
Also, fluorescent probes can cause errors in interpretation if
they detach from the nanoparticles.[4] Furthermore, photo-
bleaching can render the drug invisible for detection and
fluorescent markers can be phototoxic to cells.[3] Fluorescence
labeling can also be rather difficult or impossible. One such
example is with top-down prepared non-fluorescent drug
nanocrystals, and at the same time these represent one of
the most widely used classes of nanoparticles in the
pharmaceutical industry.
To avoid these drawbacks, label-free analytical techniques are
desirable. Among these, vibrational spectroscopic methods are
especially promising for directly visualizing biological speci-
mens and nanoparticulate drug delivery systems. These
techniques include those based on infrared[5] and Raman
spectroscopies.[6] Spontaneous Raman imaging has been used
for example to visualize deuterated liposomes,[7] polystyrene
nanoparticles,[8] and β-carotene loaded poly(D,L-lactide-co-gly-
colide) (PLGA) nanoparticles[9] in cells. However, there are
several challenges to using spontaneous Raman scattering. The
spontaneous Raman scattering cross section is small (the Raman
scattering process is relatively rare), making image acquisition
slow.[10] This limits its application in the analysis of biological
specimens. Also drug concentrations inside the cells tend to be
low, which further exacerbates issues with sensitivity and
acquisition time.
To overcome these challenges, and slow image acquisition in
particular, coherent Raman imaging techniques can be
employed. Coherent anti-Stokes Raman scattering (CARS)
microscopy is one such technique.[10] CARS microscopy exploits
a four-wave mixing process, where three ultra-fast laser pulses
are tightly focused through a high numerical aperture (NA)
objective and coherently drive molecular vibrations in the small
focal volume. At this point, the laser beams are spatially and
temporally overlapped, creating a fourth photon, which is then
detected. This process makes the technique inherently confocal
and allows rapid, label-free, non-destructive, three-dimensional
imaging, with the signal originating from molecular vibrational
resonances.[11] In addition, one-photon fluorescence interfer-
ence can be avoided, since the detected anti-Stokes signal is blue-
shifted from the excitation frequencies.[11] This technique has
become popular in biomedical applications involving cell and
tissue imaging; most often via detection of the CH2 stretching
vibrations in cellular lipid structures.[12] The number of
publications where this technique has been used to image
nanoparticle drug delivery is limited but increasing,[13,14]
highlighting the potential value of CARS in the field of drug
development and delivery.
Electron microscopy (EM) is a label-free method that has been
widely used to image cells containing nanoparticles. In this
technique, an electron beam is used as a source of illumination
and scattered electrons create image contrast. EM has the
obvious benefit of (sub)-nanometer scale spatial resolution that
allows visualization of the whole cellular content including
different organelles. It therefore follows that visualization of the
precise location of individual nanoparticles inside cell organellesBiotechnol. J. 2019, 14, 1800413 1800413 (2 of 10) © 2018 The Ais possible.[15] However, this technique lacks chemical-specificity
which can prevent, for example, correct identification of
intracellular nanoparticles.
Correlative light–electron microscopy (CLEM) is a technique
that conventionally combines fluorescence microscopy and
electronmicroscopy to image exactly the same region of interest,
such as part of a cell or certain cell organelle, consecutively with
both techniques.[16] While other imaging techniques capable of
low nanometer resolution also exist, such as super-resolution
microscopy[17] and tip-enhanced Raman imaging,[18] EM
remains the only imaging technique that can be used to
visualize whole cells in great detail, including different
organelles and associated membranes in a single image. Despite
the potential value of CLEM in the studies of cellular drug
delivery of nanoparticles, the number of publications in the area
is minimal. Recently, stimulated emission depletion (STED)
microscopy was combined with EM to image the cellular uptake
of fluorescent nanodiamonds.[19]
In the current study, CARS was synergistically combined with
TEM in a correlative manner (C-CARS-EM) to visualize
biological specimens and the cellular uptake of non-fluorescent
drug nanocrystals. Nanocrystals represent a comparatively
simple but difficult/impossible to label nanoparticle model for
this proof-of-concept study, with the added benefit that they are
widely used in the pharmaceutical industry. CARS microscopy
provides label-free chemically-specific imaging on the (sub)-
micronscale based on molecular vibrations, while TEM, with its
(sub)-nanoscale spatial resolution, provides further information
about the subcellular localization and interaction of these drug
nanocrystals. The correlative imaging setup presented, with
existing methods, allows insights into nanoparticle uptake as
well as image interpretation confidence that would not be
possible with either technique alone.2. Experimental Section
2.1. Cell Culturing
RAW 264.7 (ATCC TIB-71) macrophage cells were obtained from
ATCC,USA.Cellswereculturedat37 Candin5%CO2.Cellswere
grown in a 75 cm2 cell culturing flask (Corning Inc., USA) and
passaged every 2 to 3 days. Cell culture medium solution,
Dulbecco’s Modified Eagle’s Medium (DMEM), fetal bovine
serum (10% in total) (FBS), L-glutamine, non-essential amino
acids (NEAA), penicillin (100 IUmL1), and streptomycin
(100mgmL1) were purchased fromGEHealthcare,UK. Sodium
pyruvate (1% in total) was purchased from Thermo Fisher
Scientific, USA. Cells were passaged using cell scrapers (Corning
Inc., product no# 3010)with cells beingwashed twicewithDMEM
and 10mL of DMEM being added to the flask prior to scraping to
detach the cells. Approximately 1mL of cell suspensionwas added
to a new culturing flask with 13mL of DMEM in total. For the
uptake studies, cells with passage numbers below 10 were used.2.2. Preparation of Nanosuspensions
GLI-NC suspensions were prepared via media milling using a
Dispermat SL-C 5 bead mill (VMA Getzmann GmbH,uthors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA.
www.advancedsciencenews.com www.biotechnology-journal.comGermany). The suspension medium was double-distilled water
(FinnAqua 75, San Asalo-Sohlberg Corp., Helsinki, Finland) and
the suspension was stabilized with hydroxypropylmethyl cellu-
lose (HPMC) (METHOCEL E5 Premium LV, Dow Chemical
Company, Stade, Germany) (10% w/w relative to the drug). The
milling was performed for 320min in circulation mode with a
pump speed of 70mLmin1, rotor speed of 4000 rpm and silica
beads with a size of 1–1.2mm. The batch size was 100 g with 10 g
of glibenclamide (Alpha Aesar, Karlsruhe, Germany).2.3. CARS Microscopy
A Leica TCS SP8 CARS microscope (Leica, Germany) was used
for bright field (BF), CARS and two-photon fluorescence (TPEF)
imaging. The microscope consists of an inverted microscope
with a laser-scanning confocal scan-head and photomultiplier
tube (PMT) and GaAsP hybrid (HyD) photodetectors. The CARS
excitation source (Stokes) was a Nd:YVO4 laser with a
wavelength of 1064.5 nm. The pump and probe beams were
generated using an optical parametric oscillator (OPO). The
bandwidth of the Stokes beam was about 2–3 cm1 and the
repetition rate was 80MHz. The pulse duration was 7 ps for the
Stokes and 5–6 ps for the pump and probe beams. A water-
immersion 25 objective with a NA of 0.95 (Leica HCX IR APO
L 25 /0.95W) was used. Average powers at the focus were
approximately 30mW for Stokes beam and 43mW for pump/
probe beam. The CARS spectra of glibenclamide (GLI), HPMC
and glibenclamide nanocrystal (GLI-NC) suspensions were
measured by placing a small amount of powder or suspension on
a coverslip and systematically changing the wavelength of the
pump laser from 797 to 821 nm with 41 steps.
A HeNe laser with a wavelength of 633 nm and a power below
0.1mW was used for BF imaging. The transmitted light was
detected with a PMT detector. The Stokes beam (1064.5 nm,
power 50mW) was used to excite the CellMask Orange (Life
Technologies Corp., Carlsbad, CA, USA), for visualizing the
cells. The TPEF signal was detected with a HyD detector
(detection range 450–550 nm). Images were acquired with Leica
Application Suite Advanced Fluorescence (LASAF) software.
Spectral processing was performed using OriginPro 8.6 (Origin-
Lab, Northampton, Massachusetts, USA).2.4. Scanning Electron Microscopy
A FEI Quanta 250 Field Emission Gun Scanning Electron
Microscope (FEI, USA) was used to image unmilled GLI powder
and dried GLI-NC suspension. The samples were mounted on
aluminium stubs covered with carbon tape and then coated with
a thin layer of platinum. Micrographs were taken under low
(unmilled GLI) or high (GLI-NCs) vacuum, with a 10 kV beam
and a spot size of 4 (arbitrary units).2.5. C-CARS-EM Workflow and Image Acquisition
Cells were seeded on gridded glass-bottomed Petri dishes
(MatTek, No. 1.5, 35mm, 13mm glass diameter). RAW 264.7
macrophage cells (approximately 100 000 cells per well) wereBiotechnol. J. 2019, 14, 1800413 1800413 (3 of 10) © 2018 The Aallowed to attach to the bottom of the dish overnight. GLI-NC
suspension diluted to a concentration of 250 μgmL1 in DMEM
(2mL) was added and cells were incubated at 37 C and 5% CO2
with suspension for 6 h. Excess particles were removed and the
cells were washed twice with DMEM. Cell membranes were
stained with CellMask Orange plasma membrane stain (5 μg
mL1 in DMEM) by incubating the cells in 37 C and 5% CO2
with 1mL of stain for 5min. The stain solution was then
removed and cells were fixed with glutaraldehyde (2%) (Sigma–
Aldrich, Germany) in sodium cacodylate buffer (100mM)
(Electron Microscopy Sciences, EMS, USA) for 30min at room
temperature. Sodium cacodylate was replaced with Hank’s
balanced salt solution (HBSS, Life Technologies, USA) with 2-[4-
(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid (HEPES,
Sigma-Aldrich, Germany) (10mM) pH 7.4 buffer solution and
cells were imaged first with the CARS microscope. BF images
with the grid markings were recorded to later locate the same
cells for the preparation of TEM sections and subsequent TEM
imaging. CARS/TPEF imaging of the cells was performed with z-
stack images being recorded (step size 0.5 μm, CARS shift
3075 cm1). In addition, CARS spectra from inside the cell were
recorded by systemically tuning the pump laser 41 times to
obtain spectra between 2785 and 3150 cm1. Cells were then
post-fixed with reduced osmiumtetroxide (1%) (Electron Mi-
croscopy Sciences, USA) in Na-cacodylate buffer (100mM), pH
7.4 for 1 h at room temperature, dehydrated with graded series of
ethanol (70, 96, and 100%), incubated with transitional solvent
acetone and flat-embedded in Epon (TAAB Laboratories
Equipment Ltd, UK).[20] About 120 nm thick parallel sections
were then cut from the block face using a Leica UCT
ultramicrotome, with the area selected based on the bright
field images showing the grid markings. Sections were post-
stained with uranyl acetate and lead citrate and imaged with a
Jeol JEM-1400 TEM (Jeol Ltd., Tokyo, Japan) equipped with a
Gatan Orius SC1000B bottom mounted CCD-camera using a
80 kV beam. Entire cells were sectioned and imaged, allowing for
comparison of the entire cells imaged with both imaging
techniques. For TEM imaging of GLI-NCs without cells, the
suspension was diluted with Milli-Q water and a small droplet
was placed on a copper grid and allowed to dry prior to imaging.
The Leica Application Suite Advanced Fluorescence (LASAF)
was used for image acquisition of CARS/TPEF and BF images
and adjusting the contrast for the images. The spectral data was
processed with OriginPro 8.6 (OriginLab). Contrast for TEM
images was adjusted with Fiji Image J (open-source distribution)
and Microscopy Image Browser (MIB, version 2.01 with
MATLAB R2017b, MathWork, MA, USA)[21] and overlaying of
CARS/TPEF and TEM images was achieved by using GNU
Image Manipulation Program v2 (open-source distribution). For
the overlaid CARS/TPEF and TEM images, a CARS/TPEF image
of size 768 768 pixels, obtained with a digital magnification of
4.5 (pixel size 135 nm), was used as a template so that low
magnification (500) TEM images could be compared and
overlaid (low magnification of TEM and relatively high
magnification of CARS). Furthermore, smaller regions
(250 250 pixels) within the images were cropped and the
CARS/TPEF images within this region were positioned as the
bottom layer with the opacity adjusted. Distinguishable regions
of the cells (e.g. edges of the cell) were used as a benchmark foruthors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA.
www.advancedsciencenews.com www.biotechnology-journal.comoverlaying. The TEM images required some stretching, since
sample preparation causes some shrinkage to the cells. For the
Video S1, Supporting Information and minimum projection
image of overlaid TEM sections (Figure S6, Supporting
Information), all the TEM slices were aligned using Amira
(version 6.3, Thermo Fisher Scientific, FEI, Oregon, USA). The
frame numbers were added to the aligned images using GNU
Image Manipulation Program v2 and the final video was
rendered in MIB.3. Results and Discussion
3.1. Preparation and Characterization of Nanocrystals
Unlabeled GLI-NCs were used as the model nanoparticles. GLI-
NC suspensions were prepared using media milling. Scanning
electron microscopy (SEM) revealed that coarse GLI crystals had
prismatic morphology and individual crystals sized up to 100 μm
(Figure 1A). Particle size reduction to the nanoscale uponmilling
was confirmed by dynamic light scattering (z-average 252nm)
(Figure S1, Supporting Information) and electron microscopy
(Figure 1BandC). In theTEMimages, drugnanocrystals appeared
as dark electron-dense regions (Figure 1C). X-ray diffraction was
used to confirm that the nanoparticles remained crystalline after
milling (Figure S2, Supporting Information).
Raman and CARS spectra of coarse GLI crystals and GLI-NCs
revealed peaks due to CH2 and CH3 stretching at approximately
2840 cm1 (symmetric CH2 stretching),
[22] 2890 cm1 (symmet-
ric and asymmetric CH2 stretching),
[23] and 2935 cm1 (sym-
metric CH3 stretching)
[24] (Figure 1H and S3, Supporting
Information). A peak at 3075 cm1 is due to CH stretching in the
benzene ring.[25] This peak was chosen for chemically-specific
imaging of GLI crystals with narrowband CARS microscopy
(Figure 1E–G), since it is distinct from the CH stretching signals
of endogenous cellular lipids observed at 2856 and 2931 cm1 [26]
and the stabilizer, hydroxypropylmethyl cellulose (HPMC)
(Figure 1H).3.2. Cellular Uptake Studies
RAW 264.7 macrophage cells were used in drug nanocrystal
cellular uptake analysis. These cells were selected because
macrophage cells efficiently internalize particles with varied
sizes, providing a suitable model for this proof-of-concept study.
Control cells (Figure S4, Supporting Information) were used to
confirm that cells not incubated with GLI-NCs did not show
significant CARS signal at 3075 cm1.
Cells were incubated with GLI-NCs in cell culturing
medium for 6 h and cell membranes were stained with
CellMask Orange and fixed with glutaraldehyde. First, cells
were imaged with BF microscopy, which was also used to
visualize the grid markings on the Petri dishes so that the
same cells could later be located and imaged with TEM. Epi-
CARS imaging was subsequently performed to probe the GLI-
NCs, while cell membranes were visualized with two-photon
excited fluorescence (TPEF) using a 1064.5 nm laser (Stokes
beam). Epi-CARS detection has the benefit that it efficientlyBiotechnol. J. 2019, 14, 1800413 1800413 (4 of 10) © 2018 The Arejects solvent signal and allows highly sensitive imaging of
small features such as intracellular features or drug nano-
crystals in this case.[27] Therefore, epi-CARS imaging at
3075 cm1 was used to chemically-specifically image GLI-
NCs. In addition to CARS imaging, the same cells were
imaged with TEM to combine its (sub)-nanometer scale
spatial resolution with CARS microscopy as depicted in the
workflow chart in Figure 2A. Thus, a C-CARS-EM
imaging platform, suitable for imaging of drug nanoparticle
uptake in more detail with both chemical-specificity and (sub)-
nanometer scale spatial resolution, was developed (Figure 2B).
Based on the BF images (Figure 3A), GLI-NCs accumulated in
the vicinity of the cells after incubation. Confocal TPEF/CARS
images could, moreover, be used to confirm that GLI-NCs were
inside the cells (Figure 3B). In the C-CARS-EM analysis,
correlative CARS/TPEF and low magnification (500) TEM
images provided first a general view of a larger region of the cell
(Figure 3C–E). The information obtained from these overview
images from the corresponding three cells revealed the regions
of interest in which the localization of dark electron-dense
crystals in cells was in good correlation with the crystals imaged
with CARS (Figure 3C–E). Furthermore, in addition to single
peak epi-CARS imaging (at 3075 cm1), the CARS spectral
information could be used to confirm the chemical composition
of the overlaid spots and serve as a guide for the higher
magnification TEM images (Figure 4). It was confirmed that the
epi-CARS signal was due to the GLI based on the comparison of
the spectra measured inside the cell to the reference spectrum of
GLI-NCs, which exhibited similar features, most importantly the
peak at 3075 cm1 (Figure 4A and B). Interpretation of the EM
images of cells with nanoparticles is not always self-evident.
Cells can also naturally contain electron dense endogenous
material that can make it difficult to distinguish nanoparticles
from these endogenous structures. Also, not all nanoparticles
are necessarily electron dense and therefore may not be visible in
EM images. Here correlative imaging is beneficial; CARS can
first be used to chemically-specifically identify nanoparticles and
the correlative information from the EM images then reveals
more precisely how the nanoparticles appear together with
surrounding cellular structures.
The physical phenomenon of light diffraction ultimately
determines the absolute resolution of conventional light
microscopy and the lateral spatial resolution in ideal conditions
is approximately 200–500 nm, depending on the wavelength of
the light and numerical aperture (NA) of the objective.[28]
However, it has been demonstrated that Raman based imaging
can be used to image even smaller nanoparticles if the resulting
Raman scattering signal is sufficient. This is often the case with
specific materials such as gold or silicon, which enhance the
signal due to the electronic properties of the materials. Four-
wave mixing (FWM) microscopy is not limited to probing
vibrational resonances as in the case of CARS — it is also
sensitive to electronic properties of the materials. FWM
electronic signal enhancement can occur when one or more
of the electric fields in FWM microscopy is resonant with an
electronic transition within the material. Gold and silicon
nanomaterials, in particular, are effectively utilized this way.
Gold nanoparticles have been imaged with FWM microscopy
inside cells and it has been shown that sufficient signal foruthors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA.
Figure 1. Material characterization. (A) SEM image of unmilled GLI crystals. (B) SEM image of dried GLI-NC suspension. (C) TEM image of dried GLI-
NC suspension. (D–F) Bright field (BF) image, epi-CARS image (3075 cm1), and overlay of BF and CARS images of GLI coarse particles, respectively.
(G) Epi-CARS image (3075 cm1) of GLI-NCs in aqueous medium. (H) CARS spectra of coarse GLI, GLI-NC suspension and the stabilizer, HPMC.
www.advancedsciencenews.com www.biotechnology-journal.comdetection can be achieved from gold particles as small as
20 nm.[29] Plasmon-induced signal enhancement has also been
used to measure the Raman signal from polymer-coated gold
nanorods inside RAW 264.7 macrophages using surface-
enhanced Raman scattering (SERS).[30] Nanodiamonds have
also been detected inside live HeLa cells using CARSBiotechnol. J. 2019, 14, 1800413 1800413 (5 of 10) © 2018 The Amicroscopy.[14] Pope et al. showed that single nanodiamonds
as small as 30 nm can give a sufficient signal for detection.[14]
Such strong signals are, however, ideal cases from an analytical
perspective, and do not reflect the vast majority of drug
nanoparticles. In the current study it was shown that individual
NCs down to 500 nm give sufficient contrast in epi-CARS foruthors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA.
Figure 2. (A) Schematic presentation of the workflow of C-CARS-EM studies of cellular uptake of nanocrystals. Cells were cultured on gridded glass-
bottomed Petri dishes allowing the same cells to be located and imaged with TEM after CARS imaging. TEM specimens were prepared while cells were
still attached to the Petri dish and EM sections were prepared in the same orientation as CARS and BF imaging (flat-embedding, experimental section).
(B) Schematic illustration demonstrating the resolution of optical CARS imaging and TEM.
www.advancedsciencenews.com www.biotechnology-journal.comimaging purely relying on the detection of molecular vibrations
(Figure 5) suggesting that coherent Raman based techniques
offer label-free chemically-specific imaging with suitable spatial
resolution for imaging individual particles inside the cells.
The smallest details can only be seenwith EM,which is the only
imaging technique that can be used to truly visualize, for example,
two biological membranes touching each other, as well as
differentiate all the organelles in the field of view in high detail.
This is beneficial because it allows, for example, the precise
localization of drug nanoparticles (previously confirmed as such
using CARS) to be visualized at a highly subcellular level and,
therefore, access to information about the intracellular fate of
nanoparticles and drug uptake mechanism(s). The information
available can also be used to determine cell viability after drug
treatment based on the cellular morphology changes. High
magnification TEM images revealed that most of the GLI-NCs
were localized in the vesicles with MVB-like morphology
associated with the intraluminal vesicles (ILVs) (Figure 4Cb-
Eb).
[31] The (sub)-nanometer scale spatial resolution of TEM, could
also be used to gain information about cell viability based on the
intracellular morphology. After 6 h of incubating the cells with
GLI-NCs, the cells started to show some morphological features
that suggested cell damage with the fused vesicles starting to look
misshapen and diluted. This cell viability information was not
accessible with the conventional viability assay (Figure S5,Biotechnol. J. 2019, 14, 1800413 1800413 (6 of 10) © 2018 The ASupporting Information), as the assay, based on the detection of
luminescence signal proportional to the amount of ATP present,
indicated that cell viability was up to 90% even when cells were
incubated with a suspension of 1mgmL1 for 6 h.
Endocytosis can be roughly categorized as caveolae- and
receptor-mediated endocytosis, micropinocytosis and phagocyto-
sis, but other pathways are also known.[2] In general, in
endocytosis, the cargo is first engulfed by primary endocytic
vesicles.[31] The vesicles then undergo maturation in which they
fuse to form early endosomes (EE) or early phagosomes (EP) that
mature to late endosomes (LE) or late phagosomes (LP).[31]
Endosomes and phagosomes can fuse together and subsequently
fuse with lysosomes, then acidify and form fusions called
endolysosomes or phagolysosomes, where active degradation
occurs. Endolysosomes are the principal intracellular sites of acid
hydrolase activity.[31,32] Endolysosomes and lysosomes are also in
dynamic equilibrium in a lysosome regeneration cycle.[32] During
the maturation process, the number of ILVs in endosomes
increases.[31] ILVs can be found to some extent in EEs and,
after a period of approximately 8–15min,many ILVs can be found
in LEs. Nanoparticles can be taken up by many of these
mechanisms simultaneously.[2,33] Thus, the uptake of nano-
particles is rather complex and particle properties such as size and
surface charge, as well as cell type, can all affect the uptake
process.[2,34]uthors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA.
Figure 3. C-CARS-EM images of GLI-NCs in RAW 264.7 macrophages. (A) BF image and (B) corresponding CARS/TPEF image from the inside of the
cell. The CARS shift at 3075 cm1 was used to image GLI-NCs. TPEF originates from CellMask Orange excited with the 1064.5 nm laser. (C–E) Correlative
light microscopy (CARS/TPEF) and TEM images and overlays (from left to right) from three spots shown as boxes in image B (1–3). White arrows
indicate crystals that were visualized with both techniques. Scale bars are (A and B) 20 μm and (C–E) 5 μm.
www.advancedsciencenews.com www.biotechnology-journal.comIn this study, it was shown that GLI-NCs were located inside
vesicles with ILVs that morphologically resembled LPs and
endolysosomes/phagolysosomes (Figure 4Cb-Eb).
[31,32] In addi-
tion to the larger crystals visible in the CARS images, the TEM
images also showed smaller dark electron-dense nano-sized
(approximately 10–30 nm) particles, suggesting that the GLI-
NCs may have started to dissolve or otherwise break apart in
these acidic vesicles. Phagocytosis is expected to be the main
internalization mechanism of particles in macrophage cells.[2]
In this study, a proof-of-principle workflow and platform was
developed and proposed as an analytical platform for investigat-
ing the cellular uptake and subcellular localization ofBiotechnol. J. 2019, 14, 1800413 1800413 (7 of 10) © 2018 The Ananoparticles, as well as associated cellular changes. The
feasibility of the C-CARS-EM platform for imaging nanoparticle
cellular uptake was demonstrated successfully with GLI-NCs. In
the C-CARS-EM procedure we have performed, whole cells were
sectioned into 120 nm thick sections for TEM imaging. This
allows the visualization of the entire cell, as well as all the
nanocrystals taken up by the cells, with nanometer spatial
resolution axially and laterally. In addition, this truly allows for
correlation of the two microscopy techniques used for imaging
the same cells. The lateral resolution of the CARS setup used in
this study, as experimentally demonstrated by plotting the
intensity profile of CARS signal of individual GLI-NC anduthors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA.
Figure 4. GLI-NC cellular uptake imaged with correlative CARS/TPEF microscopy and TEM. (A) Orthogonal projection image (CARS/TPEF) of GLI-NCs
inside the RAW 264.7 macrophage. (B) CARS spectra extracted from four regions showing CARS signal at 3075 cm1 from the inside of the cells as
indicated by white arrows in image (A) along with a reference spectrum of GLI-NCs in aqueous medium. (C–E) Correlative TEM images of the same cell
imaged with CARS/TPEF. Images Cb–Eb are higher magnification images from the regions shown as black boxes in images Ca–Ea. The position of
120 nm TEM sections are also indicated as section numbers. The total number of 120 nm TEM sections was 44. Scale bars are: (A) 20 μm, (Ca–Ea)
10 μm, and (Cb–Eb) 500 nm.
www.advancedsciencenews.com www.biotechnology-journal.comdetermining full width at half maximum (FWHM), was
approximately 400 nm and the axial resolution was approxi-
mately 2 μm (Figure 5). This can be seen in the images of cells
with nanocrystals, with the corresponding CARS/TPEF image
taken from one axial plane inside the cell being compared to theBiotechnol. J. 2019, 14, 1800413 1800413 (8 of 10) © 2018 The ATEM images obtained from 120 nm sections: the CARS images
show more nanocrystals in cells compared to one TEM image.
However, most of the single TEM images show nanocrystals in
the cell. All the overlaid TEM slices could be visualized using a
minimum projection image and video, which show a largeuthors. Biotechnology Journal Published by Wiley-VCH Verlag GmbH & Co. KGaA.
Figure 5. TEM image of an individual GLI-NC in a cell (A) and corresponding xy (B) and xz (C) CARS images (3075 cm1) of the same NCwith intensity
line profiles. A fanotype line fit was applied to the xz intensity data.[39] FWHM was read from the plot.
www.advancedsciencenews.com www.biotechnology-journal.comnumber of internalized GLI-NCs (Figure S6A and Video S1,
Supporting Information). The corresponding chemically-
specific maximum projection image of the CARS/TPEF z-stack
from the same cell is also shown for comparison (Figure S6B,
Supporting Information).
The C-CARS-EM imaging approach can be extended to other
drugs and nanoparticles assuming that they generate suitable
Raman signals. The proposed method could also be useful if
nanoparticles lack sufficient electronic contrast, since CARS can
be used to probe the nanoparticles and EM can reveal other
details in cells. However, the C-CARS-EM method is the most
beneficial when nanoparticles also provide electronic contrast
during EM imaging. Despite the limited number of publications
involving CARS analysis of cellular uptake of drug nanoparticles,
the feasibility of FWM imaging has been demonstrated with
some nanoparticles commonly used in drug research. These
include for example silicon,[35] gold,[29] and polymeric nano-
particles[36] as well as nanodiamonds.[14] It has been shown that
these materials also provide suitable electronic contrast for EM
imaging. Electronic enhanced FWM microscopy has also been
used to image inorganic nanocrystals[37] and CARS has been
used to visualize non-fluorescent organic paliperidone palmitate
nano/microcrystals in cells and tissue.[38]
In the future, it is likely that integratedmicroscopes capable of
light microscopy and EM will become more common. Such
microscopes capable of fluorescence and EM imaging already
exist. [40] These systems allow faster analysis and facilitate precise
colocalization of regions in the images. Potentially, CARS
microscopy could also be integrated with EM.
4. Conclusions
In the present study, we developed and proposeC-CARS-EMas an
imagingmethod for studying nanoparticle drug delivery into cells
by synergistically combining thebenefits of two imagingmethods:
CARS microscopy and TEM. For the first time, a Raman-basedBiotechnol. J. 2019, 14, 1800413 1800413 (9 of 10) © 2018 The Aimagingmethod, specifically CARS, was combined with TEMas a
correlative imaging platform to image nanoparticle uptake and
processing within cells. CARS offers rapid, 3D and chemically-
specific imaging without labels and TEM offers (sub)-nanometer
scale spatial resolution, allowing the visualization of the contents
of whole cells at once and therefore also allowing the precise
subcellular localization of nanoparticles. The method was used to
image the uptake of GLI-NCs in RAW 264.7 macrophages. Good
correlationbetweentheCARS-activeandelectron-densecrystals in
the CARS and TEM images was observed. The images revealed
that nanocrystals were localized insidemembrane bound vesicles,
showing MVB-like morphology typical for LPs, endolysosomes
and phagolysosomes.
The informationobtainedcanbeusedtogain indepthknowledge
about subtle mechanisms by which cells take up and process
nanoparticles.Abetterunderstandingof these interactionprocesses
can lead to improved and more efficient drug development, as
nanoparticle fate inbiologicalmatrices canbevisualizedprecisely in
early drug development phases with cell models.
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